Faculty - Profile
Home >Faculty
Dr. N. Dhatchana Moorthy, M.Pharm., Ph.D
Assistant Professor
Department of Pharmaceutical Chemistry
- Email.id : dakshmin@gmail.com.
Overview
Dr. N. Dhatchana Moorthy, M.Pharm., Ph.D., is an Associate Professor in the Department of Pharmaceutical Chemistry at C. L. Baid Mehta College of Pharmacy, Chennai, where he has been serving since December 2024. He brings over 25 years of extensive experience in the pharmaceutical industry, R&D, translational research, and academia, with expertise in drug discovery, cancer biology, biotherapeutics, gene therapy, and precision medicine.
Before transitioning to academia full-time, Dr. Moorthy developed a comprehensive industrial research career within leading pharmaceutical and biotech companies. His work has encompassed small-molecule drug discovery, peptide therapeutics, biomarker research, AI-driven translational medicine, and digital innovations in pharmaceuticals. He has held senior scientific and leadership positions, contributing to programs in oncology, liver diseases, epigenetics, and targeted therapies, with experience from early discovery through preclinical and IND-enabling studies. His core scientific expertise includes molecular and cell biology, transcriptomics, assay development, recombinant protein expression, gene delivery systems, xenograft studies, and AI/ML-guided biomarker identification.
Dr. Moorthy earned his Ph.D. in Pharmaceutical Science and Biochemistry from the University of Madras and received the Prof. K. Radha Shanmugasundaram Endowment Gold Medal for the best Ph.D. thesis. He completed his M.Pharm. in Pharmaceutical Sciences with a specialization in Pharmaceutical Chemistry from IIT BHU, where he graduated as the university topper, and his B.Pharm. from The Tamil Nadu Dr. M.G.R. Medical University, with first-class and distinction.
He has authored 22 peer-reviewed publications with a combined journal impact factor of approximately 50 and more than 290 citations. He is also a co-inventor of patents related to targeted fusion proteins in cancer therapy. An active mentor, researcher, and invited speaker, Dr. Moorthy is dedicated to enhancing pharmaceutical education by integrating industry insights, research rigor, and emerging technologies to prepare students for careers in modern drug discovery and development.
Total journal impact factor: 52.392; Total citations: 292; h-index: 7
1. Jayashree, B., D. Ananthan Krishnan, N. Gopinath, E. Tharshini, N. Dhatchana Moorthy N, et al. “A Chimeric Natriuretic Peptide (Ev-NP) Inhibits Isoproterenol (ISO)-Induced Hypertrophic Growth in Vitro and In Vivo Models: In Silico Docking and Binding Efficacy Analysis with NPR-A Receptor.” Peptides, under revision, 2026. DOI: not yet assigned.
2. Balaiah, E., R. Agneswaran, N.Dhatchana Moorthy, G. Panchapakesan, P. Aswini, and A. K. Mohanakrishnan. “Synthesis of 2-Aryl/Alkylaminomethyl 17-Sulfamate/17-Methyl Estratrienes and Their In Vitro Cytotoxicity in Human Cancer Cell Cultures.” Steroids, under revision, 2026. DOI: not yet assigned.
3. Mahati, M., P. Kaur, E. Bindewald, M. Nasser, T. Srinivas, and N. Dhatchana Moorthy. “Cross-Study Transcriptomics and Machine Learning Approaches Reveal a Predictive Six-Gene Panel for Hepatocellular Carcinoma.” Medicine in OMICS, under revision, 2025. DOI: not yet assigned.
4. Elangovan, V., N. Gopinath, E. Tharshini, N. Dhatchana Moorthy, D. Suresh, and B. Jayashree. “Expression and Regulation of Npr1 Gene Coding for Natriuretic Peptide Receptor-A in Hypertrophied Heart: Mechanisms and Therapeutic Implications.” International Journal of Peptide Research and Therapeutics 32 (2026): 27. https://doi.org/10.1007/s10989-026-10806-6 [IF 2.4]
5. Prabakaran, A., S. Amuthalakshmi, N. Ramalakshmi, C. N. Nalini, N. Dhatchana Moorthy, and R. S. Viswas. “Computational Investigation and Synthesis of 6-Chlorocoumarin-Oxadiazole Hybrids for Identifying Newer Candidates against Alzheimer’s Disease Using Multi-Target Strategies.” Letters in Drug Design & Discovery (2026). https://doi.org/10.1016/j.lddd.2025.100260 [IF 1.6]
6. Suresh, T., N. Dhatchana Moorthy, G. Karthikeyan, V. Vijayakumar, J. P. Jasinski, and S. Sarveswari. “An Efficient Synthesis of Novel Aminothiazolylacetamido Substituted 3,5-Bis(arylidene)-4-Piperidone Derivatives and Their Cytotoxicity Studies.” ACS Omega 9, no. 27 (2024): 29244–29251. https://doi.org/0.1021/acsomega.4c00039 [IF 4.1]
7. Nagaraj, G., S. Dhanusu, D. M. Nachiappan, and E. Vellaichamy. “C-Type Natriuretic Peptide (CNP) Induces Cell Death and Sensitizes the Effect of Cisplatin in Human Non-Small Cell Lung Cancer Cells (A549).” International Journal of Peptide Research and Therapeutics 28 (2022): 1–10. https://doi.org/10.1007/s10989-022-10420-2 [IF 2.4]
8. Jayachandran, K., N. Dhatchana Moorthy, S. Roy Chowdhury, S. Iqbal, H. K. Majumder, et al. “Divergent Synthesis and Evaluation of In Vitro Cytotoxic Profile of 3,4-Ethylenedioxythiophenyl-2-Propen-1-One (EDOTP) Analogues.” ChemMedChem 14, no. 15 (2019): 1418–1430. https://doi.org/10.1002/cmdc.201900225 [IF 3.5]
9. Dhatchana Moorthy, N., B. Muthu Ramalingam, S. Iqbal, A. K. Mohanakrishnan, K. Gunasekaran, and E. Vellaichamy. “Novel Isothiacalothrixin B Analogues Exhibit Cytotoxic Activity on Human Colon Cancer Cells in Vitro by Inducing Irreversible DNA Damage.” PLOS ONE 13, no. 9 (2018): e0202903. https://doi.org/10.1371/journal.pone.0202903 [IF 3.2]
10. Ramalingam, B. M., N. Dhatchana Moorthy, S. Roy Chowdhury, T. Mageshwaran, E. Vellaichamy, et al. “Synthesis and Biological Evaluation of Calothrixins B and Their Deoxygenated Analogues.” Journal of Medicinal Chemistry 61, no. 3 (2018): 1285–1315. https://doi.org/10.1021/acs.jmedchem.7b01797 [IF 7.5]
11. Kathiravan, P. R., S. Muthukumaran, N. Dhatchana Moorthy, P. Aam, and M. Venugopal. “Synthesis and Characterization of Novel Chalcones of 3-Benzylidene-2-Chlorocyclohex-1-Enecarbaldehyde as Potential Anti-Proliferative Agents.” Der Pharma Chemica 10, no. 4 (2018): 153–158. DOI: not available. [IF 0.3]
12. Kathiravan, P. R., S. Muthukumaran, N. Dhatchana Moorthy, T. Shanmuganathan, and M. Venugopal. “Divergent Synthesis of Novel Dienylbenzothiazoles and Arylidene Dibenzoxazepines and Evaluation of Their Antiproliferative and Cytotoxic Properties.” Letters in Organic Chemistry 15, no. 4 (2018): 314–322. https://doi.org/10.2174/1570178614666170608083520 [IF 0.7]
13. Shanmuganathan, T., A. A. M. Prince, and N. Dhatchana Moorthy. “Synthesis, Anti-Inflammatory Activity of Picen-13-Ylmethylene Derivatives.” Archives in Organic Chemistry (2017): 67–79. https://doi.org/10.3998/ark.5550190.p010.100 [IF 1.3]
14. Shanmuganathan, T., M. Venugopal, K. Parthasarathy, N. Dhatchana Moorthy, Y. Arun, and A. A. M. Prince. “Synthesis of Novel Bis-Allyloxy and Hydroxypropoxy Derivatives of 4,5-Diaryl Thiophene-2-Carboxylic Acid and Their Biological Evaluation.” Journal of Chemical Sciences 129, no. 5 (2017): 623–636. https://doi.org/10.1007/s12039-017-1274-6 [IF 1.6]
15. Shanmuganathan, T., K. Parthasarathy, M. Venugopal, Y. Arun, N. Dhatchana Moorthy, and A. A. M. Prince. “Synthesis, In Vitro Anti-Inflammatory Activity and Molecular Docking Studies of Novel 4,5-Diarylthiophene-2-Carboxamide Derivatives.” Journal of Chemical Sciences 129, no. 1 (2017): 117–130. https://doi.org/10.1007/s12039-016-1209-7 [IF 1.6]
16. Ramalingam, B., N. Dhatchana Moorthy, E. Vellaichamy, and A. K. Mohanakrishnan. “Synthesis of Thia-Analogues of Calothrixin B Involving FeCl3-Mediated Domino Reaction.” Synlett 28, no. 1 (2016): 133–137. https://doi.org/10.1055/s-0036-1588072 [IF 2.5]
17. Karthikeyan, G., M. Paul-S., N. Dhatchana Moorthy, R. Gopalaswamy, and S. Narayanan. “Functional Characterisation of Candida albicans Hos2 Histone Deacetylase.” F1000Research 2 (2014): 238. https://doi.org/10.12688/f1000research.2-238.v3 [IF 2.6]
18. Panchapakesan, G., R. Sureshbabu, N. Dhatchana Moorthy, and A. K. Mohanakrishnan. “Synthesis and In Vitro Cytotoxicity of 2-Substituted 17-Methylene/17-β-Estratrienes.” Indian Journal of Chemistry, Section B 52B (2013): 109–121. DOI: not available. [IF 0.592]
19. Panchapakesan, G., V. Dhayalan, N. Dhatchana Moorthy, N. Saranya, and A. K. Mohanakrishnan. “Synthesis of 2-Substituted 17β-Hydroxy/17-Methylene Estratrienes and Their In Vitro Cytotoxicity in Human Cancer Cell Cultures.” Steroids 76, no. 13 (2011): 1491–1504. https://doi.org/10.1016/j.steroids.2011.08.004 [IF 2.7]
20. Chetan, B., M. Bunha, M. Jagrat, B. N. Sinha, P. Saiko, G. Graser, T. Szekeres, G. Raman, P. Rajendran, N. Dhatchana Moorthy, A. Basu, and V. Jayaprakash. “Design, Synthesis and Anticancer Activity of Piperazine Hydroxamates and Their Histone Deacetylase (HDAC) Inhibitory Activity.” Bioorganic & Medicinal Chemistry Letters 20, no. 13 (2010): 3906–3910. https://doi.org/10.1016/j.bmcl.2010.05.020 [IF 2.8]
21. Bhonde, M. R., M. L. Hanski, J. Budczies, M. Cao, B. Gillissen, N. Dhatchana Moorthy, et al. “DNA Damage-Induced Expression of p53 Suppresses Mitotic Checkpoint Kinase hMps1: The Lack of This Suppression in p53mut Cells Contributes to Apoptosis.” Journal of Biological Chemistry 281, no. 13 (2006): 8675–8685. https://doi.org/10.1074/jbc.M511333200 [IF 3.9]
22. Bhonde, M. R., M. L. Hanski, R. Magrini, N. Dhatchana Moorthy, et al. “The Broad-Range Cyclin-Dependent Kinase Inhibitor UCN-01 Induces Apoptosis in Colon Carcinoma Cells through Transcriptional Suppression of the Bcl-xL Protein.” Oncogene 24, no. 1 (2005): 148–156. https://doi.org/10.1038/sj.onc.1207842 [IF 7.5]
1. Kapil Maithal, Dhatchana Moorthy, Rama Mukherjee, Targeted fusion proteins for cancer therapy, Dabur Research Foundation, 2007, PCT/IN06/00452, WO 2007/057922.
Research Grants (Applied / Received)
1. “Bharat-HerbAI: An AI-Powered Algorithm, Curated Database, and Clinician-Researcher Dashboard for Mining, Predicting, and Documenting Indian Traditional Herbal Drug Interactions” – Co-PI, DBT Research Grant for 78 Lakhs – Status: In review.
2. “Prototype Development of an AI-Driven Siddha Herbal–Drug Interaction Dashboard for Real-Time Clinical Risk Assessment” – Tamil Nadu Higher Education – Innovation and Product Development Grant 2026, Co-PI, Research Grant for 2 Lakhs – Status: In review.
1. Kiran, A., D. Joshi, L. Balasubramanian, M. Munikoti, P. Kaur, A. Badarkhe, S. Saha, S. Irali, K. Koumudi, S. Singh, T. Aderupoko, E. Bindewald, D. Pamarthy, N. Dhatchana Moorthy, B. Wei, S. Thirunagari, and M. Alshammari. “Multi-Modal Fusion Framework for Hepatocellular Carcinoma Prediction Using Genomic, Imaging, and Clinical Data.” Poster, International Conference for Genomic Medicine 2026 (ICGM 2026), King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, Jan. 21–22, 2026.
2. Badarkhe, A., P. Kaur, M. Munikoti, S. Pawar, K. Adhikari, T. Aderupoko, N. Dhatchana Moorthy, E. Bindewald, S. Thirunagari, and M. Alshammari. “A Novel Stacked Machine Learning Model to Uncover Gene Interactions Between Multiple Extra-Hepatic Comorbidities in MASLD Disease Progression Using Transcriptomics Data.” Poster, International Conference for Genomic Medicine 2026 (ICGM 2026), King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, Jan. 21–22, 2026.
3. Bagchi, G., L. Balasubramanian, M. Alshammari, E. Bindewald, S. Thirunagari, S. Soherwardi, and N. Dhatchana Moorthy. “Precision Multimodal Diagnostics with Mobile Imaging and Hierarchical Analysis.” Poster, Symposium on Translational Research, Genomics & Emerging Technologies, KIMS Hospitals, Secunderabad, India, Aug. 30, 2025.
4. Munikoti Srikantamurthy, M., P. Kaur, M. Alshammari, E. Bindewald, S. Thirunagari, D. Pamarthy, P. B. Khanna, and N. Dhatchana Moorthy. “Revolutionizing Early Hepatocellular Carcinoma Detection: A Six-Gene Signature Powered by Machine Learning.” Poster, Symposium on Translational Research, Genomics & Emerging Technologies, KIMS Hospitals, Secunderabad, India, Aug. 30, 2025.
5. Lakshmi, B., N. Dhatchana Moorthy, T. Srinivas, and P. Deepika. “An AI-Assisted Decision Support System for Comprehensive Liver Risk Assessment.” Oral presentation, 13th International Conference on Transforming Healthcare with IT (THIT 2026), Hyderabad, India, Jan. 30–31, 2026.
6. Dhatchana Moorthy, N., B. Muthu Ramalingam, G. Karthikeyan, A. K. Mohanakrishnan, and V. Elangovan. “Drug–DNA Interaction Studies of Calothrixins and Quinocarbazoles Using Optical Methods.” Poster, 103rd Indian Science Congress, Mysuru, India, Jan. 4–7, 2016.
7. Dhatchana Moorthy, N., B. Muthu Ramalingam, G. Karthikeyan, A. Anantharaman, A. Ramamoorthy Siva, A. K. Mohanakrishnan, and V. Elangovan. “The Anticancer Spectrum and Mechanistic Studies of the Quinone Natural Product Calothrixin B and Its E-Ring-Substituted Analogues.” Poster, 34th Annual Convention of the Indian Association for Cancer Research, Rajasthan, India, Feb. 19–21, 2015.
8. Dhatchana Moorthy, N., R. Gopalaswamy, M. S. Paul, G. Karthikeyan, and S. Narayanan. “Cloning, Expression, Purification and Functional Characterization of a Recombinant Fungal Histone Deacetylase.” Poster, 1st National Science Day, Orchid Research Laboratories, Chennai, India, Feb. 28, 2011.
9. Reddy, N. D., N. Saranya, S. S. Bhamre, D. Jayaraman, Dhatchana Moorthy, D. T. S., C. G., S. Narayanan, and A. M. Roy. “Mechanistic Study of an HDAC Inhibitor (SAHA) in Solid Cancers.” Poster, IACR Satellite Meeting “Inhibition of Tumor Progression”, Thrissur, Kerala, India, Feb. 11–12, 2011.
10. Roy, A. M., S. Nidhyanandan, N. K. Reddy, M. John, S. Bhamre, D. Jayaram, Dhatchana Moorthy, and S. Narayanan. “Targeting Solid Tumors with a Distinct Synthetic Class-Selective Histone Deacetylase Inhibitor: OCID 4681-S-01.” Poster, 9th International Symposium on Targeted Anticancer Therapies (TAT 2011), Paris, France, Mar. 7–9, 2011.
11. Narayanan, S., N. Nithyanandan, Dhatchana Moorthy, F. Ahamed, N. Surendran, V. Kachadia, G. Balasubramaniam, and S. Rajagopal. “Pharmacological Characterization of OCID 4681-S-01, a Novel Class-Selective HDAC Inhibitor for Targeted Therapy of Cancer.” Poster, 8th International Symposium on Targeted Anticancer Therapies (TAT 2010), Bethesda, MD, USA, Mar. 4–6, 2010.
12. Dhatchana Moorthy, N., S. Saxena, S. Ramalingam, N. Vishveswaran, R. Praveen, and S. Rajagopal. “Expression, Purification and Functional Characterization of Recombinant HDAC1 and HDAC6 Enzymes for Screening Small-Molecule HDAC Inhibitors.” Poster, 28th Annual Convention of the Indian Association for Cancer Research and International Symposium on Emerging Challenges and Approaches in Cancer Biology, IISc, Bangalore, India, Feb. 21–24, 2009.
13. Bhonde, M., M.-T. Cao, Dhatchana Moorthy, M.-L. Hanski, H. Scheruebl, M. Notter, M. Zeitz, and C. Hanski. “SN 38 Induces a p53-Independent Mitotic Catastrophe in Colon Carcinoma Cells: Cellular and Molecular Response Analysis.” Poster, AACR 95th Annual Meeting, Orlando, FL, USA, Mar. 27–31, 2004.
14. Bhonde, M., R. Magrini, M.-L. Hanski, Dhatchana Moorthy, H. Scherübl, M. Zeitz, and C. Hanski. “Transcriptional Profile of Senescence and Apoptosis in Response to SN 38 Treatment of Colon Cancer Cells.” Poster, Arbeitsgemeinschaft Gastroenterologische Onkologie (AGO) Meeting, Bonn, Germany, 2003.
15. Magrini, R., Dhatchana Moorthy, M. Bhonde, M.-L. Hanski, M. Zeitz, and C. Hanski. “Induction of Apoptosis by 7 Hydroxystaurosporine (UCN 01) Is Affected by Activation of Two Counteracting Pathways.” Poster, AACR 94th Annual Meeting, Washington, DC, USA, July 11–14, 2003.
16. Bhonde, M. R., Dhatchana Moorthy, M.-L. Hanski, R. Magrini, M. Notter, B. Mann, H. Scheruebl, M. Zeitz, and C. Hanski. “Analysis of DNA Damage–Induced p53-Dependent and -Independent Transcriptional Response in Colorectal Carcinoma Cells Using Oligonucleotide Microarrays.” Poster, AACR 94th Annual Meeting, Washington, DC, USA, July 11–14, 2003.
17. Magrini, R., M. Bhonde, M.-L. Hanski, Dhatchana Moorthy, H. Scherübl, M. Zeitz, and C. Hanski. “Effect of p53 and Mismatch Repair Status on the Response of Colon Carcinoma Cells to Irinotecan Treatment.” Poster, Arbeitsgemeinschaft Gastroenterologische Onkologie (AGO) Meeting, Bonn, Germany, 2002.
18. Bhonde, M., Dhatchana Moorthy, R. Magrini, M.-L. Hanski, B. Mann, and C. Hanski. “Transcriptional Profile of Response During Senescence or Apoptosis in Colon Carcinoma Cells After SN 38 Treatment.” Plenary lecture, AACR NCI EORTC Meeting on Molecular Targets and Cancer Therapeutics, Frankfurt, Germany, Nov. 19–22, 2002.
19. Pandeya, S. N., N. Dhatchana Moorthy, and E. De Clercq. “Synthesis and Antibacterial, Antifungal and Anti HIV Activities of Schiff and Mannich Bases of Isatin Derivatives with Isoniazid.” Poster, International Symposium on Progress in Drug Discovery and Development Process, Indian Institute of Science, Bangalore, India, Jan. 17–19, 2001.
20. Pandeya, S. N., N. Dhatchana Moorthy, and E. De Clercq. “Recent Advances in the Molecular Biology of HIV Entry.” Poster, International Symposium on Recent Advances in Molecular Biology of Allergy and Immunology, Vadodara, India, Sept. 3–5, 2000.
21. Pandeya, S. N., N. Dhatchana Moorthy, and J. Venkatesan. “Synthesis and Screening for Antibacterial and Anti HIV Activities of Some N-Norfloxacin Mannich Bases of Isatin.” Oral presentation, 52nd Indian Pharmaceutical Congress, Hyderabad, India, Dec. 1–3, 2000.
22. Pandeya, S. N., J. Venkatesan, and N. Dhatchana Moorthy. “Synthesis and Antimicrobial Activities of Certain Aminopyrimidines and Their Ureas.” Poster, 51st Indian Pharmaceutical Congress, Indore, India, Dec. 18–21, 1999.
1. “AI Accelerates Drug Discovery—From Bench to Bedside: How Artificial Intelligence Transforms Therapeutics.” Invited talk, one-day national symposium on Industry Oriented Training Programme–Pharma Academia, Sir Isaac Newton College of Pharmacy, Nagapattinam, Tamil Nadu, February 28, 2026.
2. “Emerging Therapeutic Trends and Career Opportunities for Pharmacy Graduates.” Invited talk, Viveknandha College of Pharmacy for Women, Sankari, Tamil Nadu, February 12, 2026.
3. “AI Accelerates Drug Discovery—From Bench to Bedside: How Artificial Intelligence Transforms Therapeutics.” Invited talk, e-FDP on AI for Translation Medicine: Bridging Bench to Bedside, Rathinam College of Pharmacy, Coimbatore, Tamil Nadu, December 2, 2025.
4. “Integrating AI into Drug Design: Advances in Computational Chemistry, A New Era in Drug Discovery.” Guest lecture, International Conference on Pharmanext Global 2025: A Convergence of Innovation, Integration, and Educational Progress in Pharmacy, Erode College of Pharmacy, Erode, Tamil Nadu, July 1, 2025.
5. “Overview of Artificial Intelligence/Machine Learning/Deep Learning (AI/ML/DL) and Data Science.” Guest lecture, School of Pharmaceutical Sciences, Vels Institute of Technology & Sciences, Chennai, Tamil Nadu, April 11, 2025.
6. “Code to Cure—Evolving Pharma Research in the AI Era.” Invited talk, Faculty Development Programme, Rathinam College of Pharmacy, Coimbatore, Tamil Nadu, May 25, 2025.
7. “Evolving Therapeutics and Advanced Formulation Strategies.” Guest lecture, Vels Institute of Pharmaceutical Sciences, Chennai, Tamil Nadu, May 18, 2025.
8. “A New Era in Drug Discovery—Artificial Intelligence and Natural Therapeutics.” Guest lecture, SRM College of Pharmaceutical Sciences, Chennai, Tamil Nadu, March 26, 2025.
9. “AI in NAFLD/NASH Treatment—Role of Machine Learning in Drug Discovery.” Invited talk, Department of Computer Science and AI, Sathyabama Institute of Technology, Chennai, Tamil Nadu, March 12, 2025.
10. “Evolving Drug Landscape Opportunities for Pharma Graduates.” Invited talk, Swathi College of Pharmacy, Nellore, Andhra Pradesh, December 26, 2024.
11. “Innovations in Targeted Drug Delivery for Cancer Treatment: The Future of Personalized Medicine.” Invited talk, Research Colloquium Day, Hindustan Institute of Technology and Sciences, Chennai, Tamil Nadu, August 30, 2024.
12. “Strategies and Opportunities in Small Molecule and Biomolecular Therapies.” Invited talk, C. L. Baid Mehta College of Pharmacy, Chennai, Tamil Nadu, August 11, 2024.
13. “Changing Drug Landscapes: Biomolecular Therapeutics.” Invited talk, two-day national seminar on Innovative Breakthroughs in Pharmacare: Nurturing the Future Pharmacists–2023, Viveknandha College of Pharmacy for Women, Sankari, Tamil Nadu, August 11, 2023.
14. “Therapeutic Landscapes, Biologicals and Career Options.” Series of three guest lectures, Skill-Based Internship Programme on Molecular Drug Discovery Internship and Industrial Programme 2022–23, University of Madras, RUSA 2.0 Entrepreneurship & Career Hub, Guindy Campus, Tamil Nadu, June 9–July 6, 2023.
15. “Artificial Intelligence and Machine Learning in Drug Discovery and Development.” Invited talk, two-month PhD programme, Channabasweshwar Pharmacy College (Degree), Latur, Maharashtra, May 11, 2023.
16. “Why Artificial Intelligence/Machine Learning in Drug Discovery and Development?” Invited talk, two-day international conference on Global Trends in Drug Delivery Technology and Its Regulatory Compliances: An Industrial Perspective, Arulmigu Kalasalingam College of Pharmacy, Krishnankoil, Tamil Nadu, March 4, 2023.
17. “Newer Biologics for Cancer Treatment—Cell, Gene, and Immunotherapy.” Guest lecture, one-day national-level seminar/CEP Programme on Recent Trends in Drug Discovery and Development, Kasthooribha Gandhi Pharmacy College, Namakkal, Tamil Nadu, October 29, 2022.
18. “Drug Repurposing—Computational Approaches in the Era of Artificial Intelligence.” Online lecture, one-day conference on Emerging Approaches in Drug Discovery: Artificial Intelligence and Drug Repurposing Perspective, KLE College of Pharmacy, Hubballi, March 14, 2022.
19. “Pharmaceutical Industry Opportunities for Postgraduates.” Career guidance talk, Amity Institute of Virology & Immunology, Amity University, Greater Noida, Uttar Pradesh, August 10, 2021.
20. “Drug Discovery and Development in the Era of Artificial Intelligence.” Invited talk, virtual webinar, Pharmacology Education and Research Forum, June 27, 2021.
21. “Drug Discovery from Biomolecules (DNA, RNA and Protein).” Online lecture, AICTE-sponsored Quality Improvement Programme on Recent Advances in Experimental Pharmacology, KLE College of Pharmacy, Belagavi, March 1–6, 2021.
22. “Biochemical Evaluation of Synthetic Analogues of Quinone-Containing Calothrixin B: A Medicinal Chemistry Perspective.” Refresher lecture, UGC Sponsored Refresher Course in Chemistry, Batch XXVIII, Department of Organic Chemistry, University of Madras, Chennai, Tamil Nadu, February 8, 2021.
23. “Biologics and Biosimilars—An Overview of Product Development” and “Biopharmaceutical Industries in India—Opportunities for Life Science Graduates.” Internship lectures, Skill-Based Internship in Protein Biology, Department of Biochemistry, University of Madras, Chennai, Tamil Nadu, December 20 and 22, 2020.
24. “Artificial Intelligence (AI)/Machine Learning (ML) for Drug Discovery.” Invited talk, virtual webinar, Pharmacology Education and Research Forum, November 8, 2020.
25. “Next Generation Sequencing and Its Application in Drug Discovery.” Guest lecture, webinar series on Drug Discovery in the Genomic Era, Department of Biochemistry, University of Madras, Chennai, Tamil Nadu, August 19, 2020.
26. “Multi-Omics Approaches for Drug Discovery Using Artificial Intelligence (AI)/Machine Learning (ML) Techniques.” Invited talk, international virtual conference on Innovation and Recent Trends in Genomic Research, Department of Biotechnology, Bannari Amman Institute of Technology, Sathyamangalam, Erode, Tamil Nadu, July 31, 2020.
27. “Understanding COVID-19 Virology, Therapy and Its Diagnosis.” Guest lecture, international webinar series, Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, May 19, 2020.
28. “COVID-19: Basic Virology, Diagnosis, Vaccines and Therapeutic Targets for Pharmacists.” Guest lecture, webinar series, JKK Nattraja College of Pharmacy, Komarapalayam, Tamil Nadu, May 11, 2020.
29. “Modern Arsenals for Cancer Therapy—A Pharmacist View.” Guest lecture, national seminar on Pharmacological Modeling in Drug Discovery: Recent Developments, Arulmigu Kalasalingam College of Pharmacy, Srivilliputtur, Tamil Nadu, February 29, 2020.
30. “Frontiers in Cancer Therapy.” Awareness talk, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, February 4, 2020.
31. “Drug Discovery Research—Carbazoles as Anti-Cancer Drugs.” Expert talk, one-day national seminar on Recent Advances in Medicinal Chemistry for Drug Design and Drug Development (RAMC-DD & DD), Vivekanandha Pharmacy College for Women, Sankari, Tamil Nadu, January 31, 2020.
32. “Modern Vaccines and Drug Design for Emerging/Re-Emerging Infectious Diseases.” Talk, third national symposium on Emerging Infectious Diseases and Novel Drug Development (EID-NDD 2019), Swami Vivekanandha College of Pharmacy, Tiruchengodu, Tamil Nadu, December 6–7, 2019.
33. “Nanoformulations for Cancer Therapy.” Guest lecture, one-day national seminar on Pioneering in Nanoformulations and Its Futuristic Role in Pharmacy, Padmavathy College of Pharmacy, Dharmapuri, Tamil Nadu, December 15, 2018.
34. “Biology of Cancer.” Expert talk, Asan Memorial College of Arts & Science, Chennai, Tamil Nadu, August 14, 2018.
35. “Biopharmaceuticals—An Insight into Product Development.” Expert talk, Devaki Amma Memorial College of Pharmacy, Chelembra, Kerala, December 12, 2017.
36. “Nanobiotechnology in Drug Discovery and Development.” Guest lecture, one-day national seminar, SA Raja College of Pharmacy, Vadakangulam, Tamil Nadu, November 27, 2017.
37. “Pharmacy and Pharmacology of Biosimilars.” Expert talk, one-day national seminar, JKK Nattraja College of Pharmacy, Komarapalayam, Tamil Nadu, November 29, 2016.
38. “Drug Discovery—A Genomic Perspective.” Guest lecture, Kumaraguru College of Technology, Coimbatore, Tamil Nadu, September 4, 2015.
39. “Medicinal Plants in Drug Discovery—Impacts and Opportunities for Pharmacy Graduates.” Expert talk, one-day national seminar on Medicinal Plant Research: Opportunities and Challenges, SA Raja College of Pharmacy, Vadakangulam, Tamil Nadu, December 20, 2014.
40. “Recent Trends in Drug Discovery Research—A Perspective.” Expert talk, UGC-sponsored national seminar on Recent Advances in Pharma Research (RAPR-2014), SKU College of Pharmaceutical Sciences, SK University, Anantapur, Andhra Pradesh, March 14–15, 2014.
1. J.K.K Natarajah Memorial Medallion for the Best Outgoing Student in B.Pharm | 1998 Qualified
2. Graduate Aptitude Test in Engineering [GATE-98, Score: 95.33, All India rank: 110, Total appeared: 2629] | 1998
3. Post-graduate Research Fellowship from University Grants Commission, India |1998
4. Best PhD thesis award and Prof. K. Radha Shanmugasundram Endowment gold medal | 2020